Earnings Report Digest

Abbott Laboratories (ABT), 2025 Q2 earnings digest

1 min · 18. juli 2025
episode Abbott Laboratories (ABT), 2025 Q2 earnings digest cover

Description

$ABT has released its Q2 2025 earnings, where EPS of $1.26 met expectations while revenue reached $11.14B, reflecting a 7.37% year-over-year increase. Despite a 1.5% decline in diagnostics sales, particularly in COVID testing, other divisions showed resilience with medical devices growing by 12%. Key risks include ongoing headwinds from COVID impacts and geopolitical issues in China. Future opportunities hinge on product advancements, especially in diabetes care and biosimilars. 📊✨ For more details, check valueverge.com/ABT.

Comments

0

Be the first to comment

Sign up now and become a member of the Earnings Report Digest community!

Get Started

1 month for 9 kr.

Then 99 kr. / month · Cancel anytime.

  • Podcasts kun på Podimo
  • 20 lydbogstimer pr. måned
  • Gratis podcasts

All episodes

469 episodes